Papa Joseph C
CEO at PRGO; President and CEO at PERRIGO CO
- Sold, on record
- $42.3M
- Dollars the filings state
- Form 4 sales
- 36
- Latest Dec 28, 2015
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- PRGOPERRIGO Co plcCEO
- PERRIGO COPresident and CEO
Sales by reason
0
Routine
35
Plan not stated
0
No plan
1
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- PERRIGO CO389,737 shares
- PRGO30,183 shares
Shares sold, every Form 4 sale on record.
Timeline
- Dec 28, 2015Plan not stated
Sold 7.9% of their holdings
$1.5M10,183 shares at $147.07
- Mar 24, 2014Plan not stated
Sold 9.5% of their holdings
$1.6M10,000 shares at $157.71
- Feb 14, 2014Plan not stated
Sold 4.9% of their holdings
$753k5,000 shares at $150.51
- Jan 16, 2014Plan not stated
Sold 4.9% of their holdings
$788k5,000 shares at $157.59
- Dec 12, 2013Plan not stated
Sold 11.4% of their holdings
$2.3M15,000 shares at $150.12
- Sep 24, 2013Plan not stated
Sold 11.4% of their holdings
$1.9M15,000 shares at $124.60
- Aug 27, 2013Plan not stated
Sold 11.2% of their holdings
$1.8M15,000 shares at $117.64
- Jul 11, 2013Plan not stated
Sold 9.1% of their holdings
$1.3M10,000 shares at $128.54
- Jun 14, 2013Plan not stated
Sold 9.1% of their holdings
$1.2M10,000 shares at $118.39
- May 15, 2013Plan not stated
Sold 4.8% of their holdings
$603k5,000 shares at $120.51
10 of 36
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 2, 2026 | CADL | Director | AwardedStock Option (Right to Buy) | 1,325 | $8.68 | $11k | 1,325 | SEC |
| Jun 30, 2026 | Jul 1, 2026 | CADL | Director | AwardedStock Option (Right to Buy) | 1,331 | $8.64 | $11k | 1,331 | SEC |
| Jun 23, 2026 | Jun 24, 2026 | CADL | Director | AwardedStock Option (Right to Buy) | 32,000 | 32,000 | SEC | ||
| Jun 10, 2026 | Jun 12, 2026 | MIST | Director | AwardedStock Option (right to buy) | 77,000 | 77,000 | SEC | ||
| Apr 29, 2026 | May 1, 2026 | EBS | President and CEO | Awarded | 187,708 | 493,153 | SEC | ||
| Mar 31, 2026 | Apr 2, 2026 | CADL | Director | AwardedStock Option (Right to Buy) | 2,795 | $4.11 | $11k | 2,795 | SEC |
| Mar 5, 2026 | Mar 5, 2026 | EBS | President and CEO | Withheld for tax | 37,055 | $8.44 | $313k | 305,445 | SEC |
| Mar 3, 2026 | Mar 5, 2026 | EBS | President and CEO | AwardedEmployee Stock Option (Right to buy) | 252,194 | 1.8M | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Director | AwardedSeries A Common Warrants (right to buy) | 200,000 | 100,000 | SEC | ||
| Jul 11, 2025 | Jul 15, 2025 | MIST | Director | Awarded | 100,000 | 100,000 | SEC | ||
| Jun 25, 2025 | Jun 26, 2025 | CADL | Director | Awarded | 64,239 | $4.67 | $300k | 64,239 | SEC |
| Jun 17, 2025 | Jun 18, 2025 | CADL | Director | AwardedStock Option (Right to Buy) | 14,240 | 14,240 | SEC | ||
| Jun 10, 2025 | Jun 12, 2025 | MIST | Director | AwardedStock Option (right to buy) | 40,000 | 40,000 | SEC | ||
| May 13, 2025 | May 15, 2025 | EBS | President and CEO | Bought | 60,000 | $5.83 | $350k | 342,500 | SEC |
| Mar 12, 2025 | Mar 12, 2025 | EBS | President and CEO | AwardedEmployee Stock Options (Right to Buy) | 500,000 | 1.5M | SEC | ||
| Mar 6, 2025 | Mar 10, 2025 | EBS | President and CEO | AwardedEmployee Stock Options (Right to Buy) | 282,500 | 1M | SEC | ||
| Mar 6, 2025 | Mar 10, 2025 | EBS | President and CEO | Awarded | 282,500 | 282,500 | SEC | ||
| Sep 3, 2024 | Sep 5, 2024 | MIST | Director | AwardedStock Option (right to buy) | 80,000 | 80,000 | SEC | ||
| Jun 26, 2024 | Jun 27, 2024 | CADL | Director | AwardedStock Option (Right to Buy) | 14,240 | 14,240 | SEC | ||
| Mar 13, 2024 | Mar 15, 2024 | EBS | President and CEO | AwardedEmployee Stock Options (Right to Buy) | 750,000 | 750,000 | SEC | ||
| Jun 28, 2023 | Jun 29, 2023 | CADL | Director | AwardedStock Option (Right to Buy) | 14,240 | 14,240 | SEC | ||
| Jun 16, 2023 | Jun 16, 2023 | Prometheus Biosciences, Inc. | Director | Returned to the companyStock Option (right to buy) | 89,708 | 0 | SEC | ||
| Jun 16, 2023 | Jun 16, 2023 | Prometheus Biosciences, Inc. | Director | Returned to the company | 17,278 | 0 | SEC | ||
| Jun 2, 2023 | Jun 2, 2023 | Prometheus Biosciences, Inc. | Director | Other | 20,000 | 10,000 | SEC | ||
| May 19, 2023 | May 19, 2023 | Prometheus Biosciences, Inc. | Director | Awarded | 2,278 | 17,278 | SEC | ||
| Dec 9, 2022 | Dec 12, 2022 | CADL | Director | Bought | 38,032 | $1.92 | $73k | 38,032 | SEC |
| Aug 8, 2022 | Aug 10, 2022 | CADL | Director | AwardedStock Option (Right to Buy) | 28,480 | 28,480 | SEC | ||
| May 19, 2022 | May 20, 2022 | Prometheus Biosciences, Inc. | Director | AwardedStock Option (Right to Buy) | 22,551 | 22,551 | SEC | ||
| May 10, 2022 | May 12, 2022 | BHC | Director | Exercised or settledRestricted Share Units | 366,130 | $9.40 | $3.4M | 0 | SEC |
| May 10, 2022 | May 12, 2022 | BHC | Director | Exercised options | 366,130 | 1.5M | SEC | ||
| May 10, 2022 | May 12, 2022 | BHC | Director | Withheld for tax | 33,714 | $9.40 | $317k | 1.4M | SEC |
| May 10, 2022 | May 12, 2022 | BHC | Director | AwardedRestricted Share Units | 366,130 | 0 | SEC | ||
| May 5, 2022 | May 9, 2022 | BLCO | CEO & Chairman | AwardedNon-Qualified Stock Options (right to purchase) | 1.9M | 1.9M | SEC | ||
| May 5, 2022 | May 9, 2022 | BLCO | CEO & Chairman | Awarded | 472,222 | 472,222 | SEC | ||
| Mar 3, 2022 | Mar 7, 2022 | BHC | CHAIRMAN & CEO | Withheld for tax | 12,643 | $23.61 | $299k | 1.1M | SEC |
| Feb 28, 2022 | Mar 2, 2022 | BHC | Chairman & CEO | Withheld for tax | 131,855 | $24.34 | $3.2M | 1.1M | SEC |
| Feb 27, 2022 | Mar 2, 2022 | BHC | Chairman & CEO | Exercised or settledRestricted Share Units | 208,231 | $24.35 | $5.1M | 0 | SEC |
| Feb 27, 2022 | Mar 2, 2022 | BHC | Chairman & CEO | Exercised options | 208,231 | 1.2M | SEC | ||
| Feb 27, 2022 | Mar 2, 2022 | BHC | Chairman & CEO | AwardedRestricted Share Units | 208,231 | 0 | SEC | ||
| Nov 14, 2021 | Nov 16, 2021 | Prometheus Biosciences, Inc. | Director | AwardedStock Option (Right to Buy) | 2,165 | 2,165 | SEC | ||
| Sep 14, 2021 | Sep 15, 2021 | BHC | CHAIRMAN & CEO | Withheld for tax | 8,559 | $28.88 | $247k | 1M | SEC |
| Mar 16, 2021 | Mar 16, 2021 | Prometheus Biosciences, Inc. | Director | Bought | 15,000 | $19.00 | $285k | 15,000 | SEC |
| Mar 10, 2021 | Mar 10, 2021 | BHC | CHAIRMAN & CEO | Withheld for tax | 231,188 | $32.97 | $7.6M | 1M | SEC |
| Mar 8, 2021 | Mar 10, 2021 | BHC | CHAIRMAN & CEO | Exercised or settledRestricted Share Units | 317,089 | 0 | SEC | ||
| Mar 8, 2021 | Mar 10, 2021 | BHC | CHAIRMAN & CEO | Exercised options | 317,089 | 1.2M | SEC | ||
| Mar 8, 2021 | Mar 10, 2021 | BHC | CHAIRMAN & CEO | Awarded | 108,254 | 1.3M | SEC | ||
| Mar 3, 2021 | Mar 5, 2021 | BHC | CHAIRMAN & CEO | AwardedNon-qualified Stock Options (right To Purchase) | 196,464 | 196,464 | SEC | ||
| Mar 3, 2021 | Mar 5, 2021 | BHC | CHAIRMAN & CEO | Awarded | 74,150 | 845,823 | SEC | ||
| Mar 1, 2021 | Mar 3, 2021 | BHC | CHAIRMAN & CEO | Withheld for tax | 28,192 | $31.42 | $886k | 771,673 | SEC |
| Sep 15, 2020 | Sep 16, 2020 | BHC | CHAIRMAN & CEO | Withheld for tax | 8,738 | $15.70 | $137k | 799,865 | SEC |
Page 1
Sales and notices (36)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 28, 2015 | Dec 30, 2015 | PRGO | CEO | Form 4 sale | 10,183 | $1.5M | 7.9% | Plan not stated | SEC |
| Mar 24, 2014 | Mar 26, 2014 | PRGO | President and CEO | Form 4 sale | 10,000 | $1.6M | 9.5% | Plan not stated | SEC |
| Feb 14, 2014 | Feb 19, 2014 | PRGO | President and CEO | Form 4 sale | 5,000 | $753k | 4.9% | Plan not stated | SEC |
| Jan 16, 2014 | Jan 21, 2014 | PRGO | President and CEO | Form 4 sale | 5,000 | $788k | 4.9% | Plan not stated | SEC |
| Dec 12, 2013 | Dec 16, 2013 | PERRIGO CO | President and CEO | Form 4 sale | 15,000 | $2.3M | 11.4% | Plan not stated | SEC |
| Sep 24, 2013 | Sep 26, 2013 | PERRIGO CO | President and CEO | Form 4 sale | 15,000 | $1.9M | 11.4% | Plan not stated | SEC |
| Aug 27, 2013 | Aug 29, 2013 | PERRIGO CO | President and CEO | Form 4 sale | 15,000 | $1.8M | 11.2% | Plan not stated | SEC |
| Jul 11, 2013 | Jul 15, 2013 | PERRIGO CO | President and CEO | Form 4 sale | 10,000 | $1.3M | 9.1% | Plan not stated | SEC |
| Jun 14, 2013 | Jun 18, 2013 | PERRIGO CO | President and CEO | Form 4 sale | 10,000 | $1.2M | 9.1% | Plan not stated | SEC |
| May 15, 2013 | May 17, 2013 | PERRIGO CO | President and CEO | Form 4 sale | 5,000 | $603k | 4.8% | Plan not stated | SEC |
| Apr 9, 2013 | Apr 11, 2013 | PERRIGO CO | President and CEO | Form 4 sale | 10,645 | $1.3M | 9.6% | Plan not stated | SEC |
| Mar 12, 2013 | Mar 14, 2013 | PERRIGO CO | President and CEO | Form 4 sale | 15,000 | $1.7M | 12.4% | Plan not stated | SEC |
| Feb 14, 2013 | Feb 19, 2013 | PERRIGO CO | President and CEO | Form 4 sale | 5,000 | $560k | 4.1% | Plan not stated | SEC |
| Jan 17, 2013 | Jan 22, 2013 | PERRIGO CO | President and CEO | Form 4 sale | 5,000 | $523k | 4.1% | Plan not stated | SEC |
| Dec 14, 2012 | Dec 18, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 15,000 | $1.6M | 11.5% | Plan not stated | SEC |
| Nov 15, 2012 | Nov 19, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 15,000 | $1.5M | 11.5% | Plan not stated | SEC |
| Oct 10, 2012 | Oct 12, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 15,000 | $1.8M | 11.5% | Plan not stated | SEC |
| Sep 21, 2012 | Sep 25, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 15,000 | $1.7M | 11.5% | Plan not stated | SEC |
| Aug 30, 2012 | Sep 4, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 10,000 | $1.1M | 8.0% | Plan not stated | SEC |
| Jul 18, 2012 | Jul 20, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 10,000 | $1.1M | 9.1% | Plan not stated | SEC |
| Jun 20, 2012 | Jun 22, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 10,000 | $1.1M | 9.1% | Plan not stated | SEC |
| May 21, 2012 | May 23, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 15,912 | $1.6M | 13.7% | Plan not stated | SEC |
| Apr 19, 2012 | Apr 23, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 5,000 | $533k | 4.3% | Plan not stated | SEC |
| Mar 22, 2012 | Mar 26, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 5,000 | $511k | 4.3% | Plan not stated | SEC |
| Feb 22, 2012 | Feb 24, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 5,000 | $469k | 4.3% | Plan not stated | SEC |
| Jan 19, 2012 | Jan 23, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 5,000 | $500k | 4.3% | Plan not stated | SEC |
| Dec 29, 2011 | Jan 3, 2012 | PERRIGO CO | President and CEO | Form 4 sale | 10,000 | $991k | 8.3% | Plan not stated | SEC |
| Nov 22, 2011 | Nov 23, 2011 | PERRIGO CO | President and CEO | Form 4 sale | 10,180 | $910k | 8.4% | Plan not stated | SEC |
| Oct 24, 2011 | Oct 26, 2011 | PERRIGO CO | President and CEO | Form 4 sale | 10,000 | $986k | 8.2% | Plan not stated | SEC |
| Sep 22, 2011 | Sep 26, 2011 | PERRIGO CO | President and CEO | Form 4 sale | 10,000 | $933k | 8.2% | Plan not stated | SEC |
| Aug 23, 2011 | Aug 25, 2011 | PERRIGO CO | President and CEO | Form 4 sale | 5,000 | $442k | 4.8% | Plan not stated | SEC |
| Apr 25, 2011 | Apr 27, 2011 | PERRIGO CO | President and CEO | Form 4 sale | 21,000 | $1.9M | 16.9% | Plan not stated | SEC |
| Mar 22, 2011 | Mar 24, 2011 | PERRIGO CO | President and CEO | Form 4 sale | 21,000 | $1.6M | 16.1% | Plan not stated | SEC |
| Feb 22, 2011 | Feb 23, 2011 | PERRIGO CO | President and CEO | Form 4 sale | 21,000 | $1.6M | 15.4% | Plan not stated | SEC |
| Nov 25, 2009 | Nov 30, 2009 | PERRIGO CO | President and CEO | Form 4 sale | 20,000 | $812k | 19.6% | Plan not stated | SEC |
| Dec 2, 2008 | Dec 3, 2008 | PERRIGO CO | President and CEO | Form 4 sale | 30,000 | $991k | 29.9% | Unusual | SEC |